JB Chemicals & Pharmaceuticals ltd (JB Pharma), one of the fastest growing pharmaceutical companies in India, entered into an agreement with Glenmark Pharmaceuticals Ltd to acquire the Razel (Rousvastatin) franchise for the India and Nepal region. The transaction is expected to be closed within next two weeks subject to customary closing formalities.
source https://www.pharmatutor.org/pharma-news/2022/jb-pharma-to-acquire-razel-rousvastatin-franchise-from-glenmark-pharma
No comments:
Post a Comment